Related Experiment Videos
Heterologous gene expression from transmissible gastroenteritis virus replicon particles
Kristopher M Curtis1, Boyd Yount, Ralph S Baric
1Department of Microbiology and Immunology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-7400, USA.
Journal of Virology
|January 5, 2002
Summary
Researchers developed infectious Transmissible Gastroenteritis Virus (TGEV) replicon particles (VRPs) for studying TGEV replication and creating new swine vaccines. These TGEV VRPs efficiently express genes and can be used to generate novel vaccine candidates.
Area of Science:
- Virology
- Molecular Biology
- Vaccinology
Background:
- Transmissible Gastroenteritis Virus (TGEV) is a significant swine pathogen.
- Previous research established infectious TGEV constructs for genetic manipulation.
- Understanding TGEV replication and assembly is crucial for disease control and vaccine development.
Purpose of the Study:
- To construct and characterize infectious TGEV replicon particles (TGEV VRPs).
- To develop a packaging system for TGEV VRPs using a Venezuelan equine encephalitis (VEE) replicon vector.
- To evaluate the potential of TGEV VRPs for studying viral replication and as a basis for novel swine vaccines.
Main Methods:
- Generation of a recombinant TGEV expressing green fluorescent protein (GFP) by replacing ORF 3A.
- Construction of TGEV replicon RNAs lacking essential viral budding genes (ORF 3B, E, and M).
- Development of a VEE-based packaging system to produce TGEV VRPs encoding the TGEV E protein.
Main Results:
- Recombinant TGEV-GFP2 replicated efficiently and expressed GFP in baby hamster kidney (BHK) cells.
- TGEV replicon RNAs replicated but did not produce infectious virus, demonstrating single-hit dependence.
- Packaging TGEV replicon RNAs with a VEE-TGEV(E) helper system produced infectious TGEV VRPs capable of gene expression and replication in swine testicular (ST) cells without generating infectious virus.
Conclusions:
- The developed TGEV VRP system is replication-competent and capable of expressing heterologous genes.
- This system provides a valuable tool for investigating TGEV replication and assembly mechanisms.
- TGEV VRPs represent a promising platform for the development of novel swine vaccines against TGEV.